Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating radioimmunoguided intensity-modulated radiotherapy for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases [Phase 3]
Clinical trial update of a Phase 3 study evaluating neural stem cell-preserving brain radiation therapy with stereotactic radiosurgery in pa…
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy [Phase 3]
Phase 3 trial comparing epidural hydromorphone to hydromorphone infusion for pain management in prostate cancer patients undergoing radical …
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Atrasentan in Treating Patients With Prostate Cancer [Phase 3]
This document reports the completion of a Phase 3 trial evaluating atrasentan for prostate cancer, sponsored by Abbott.
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer [NA]
This update reports on a completed trial evaluating MRI and MR spectroscopy imaging to determine the extent of disease in prostate cancer pa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-02-15Clinical Trial Update: Cone Beam CT for Daily Image Guidance - Prostate Cancer [Phase 2]
A Phase 2 trial update describing the use of cone beam CT for daily image guidance in prostate cancer; the study has completed.
-
CLINICAL_TRIALS research · 2011-02-14Clinical Trial Update: Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients
An observational registry update documenting treatment patterns in castration-resistant prostate cancer; the study sponsored by Sanofi has b…
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: Exercise and Cognitive-psychosocial Functions in Men With Prostate Cancer Receiving Androgen Depletion Therapy [NA]
This clinical trial update notes the completion of a study evaluating exercise and cognitive-psychosocial interventions for men with prostat…
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: Exercise in Men With Prostate Cancer [NA]
A clinical trial investigating exercise in men with prostate cancer sponsored by the University of Manitoba has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-28Clinical Trial Update: Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies [Phase 1, Phase 2]
This update presents safety and pharmacokinetic data from a Phase 1/2 trial of orally administered gallium maltolate in refractory malignanc…
-
CLINICAL_TRIALS trial_result · 2011-01-27Clinical Trial Update: Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer [Phase 3]
A Phase 3 trial evaluated two regimens of tamoxifen (Nolvadex) to prevent Casodex-induced gynecomastia in men with prostate cancer; the stud…
-
FDA approval · 2011-01-25FDA Approved: RECLAST — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for RECLAST (zoledronic acid) filed by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer [Phase 1]
Phase I study of BMS-641988 in Japanese patients with castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer [Phase 1]
This entry describes a Phase I dose-escalation trial of the investigational agent BMS-641988 in men with castration-resistant prostate cance…
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer [Phase 2]
Update on a Phase 2 trial evaluating the combination of Casodex (bicalutamide) and Iressa (gefitinib) for locally advanced prostate cancer; …
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Casodex - Nolvadex Combination [Phase 2]
A Phase 2 trial evaluating the combination of Casodex (bicalutamide) and Nolvadex (tamoxifen) for prostate cancer and gynecomastia has been …
-
CLINICAL_TRIALS trial_result · 2011-01-21Clinical Trial Update: Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer [Phase 1]
Phase 1 study to assess safety and tolerability of AZD2171 (cediranib) after multiple doses in patients with advanced prostate cancer; the t…
-
CLINICAL_TRIALS trial_result · 2011-01-20Clinical Trial Update: Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating docetaxel plus immunotherapy before prostatectomy in high-risk prostate cancer was terminated. Results were posted …
-
FDA label_change · 2011-01-14FDA Approved: ZOLADEX — Supplemental Application (TerSera Therapeutics LLC)
FDA approved a supplemental application for ZOLADEX (goserelin) from TerSera Therapeutics LLC. The approval includes changes to the product …
-
FDA approval · 2011-01-14FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
The FDA approved a supplemental application for TRELSTAR (triporelin pamoate) filed by Verity Pharmaceuticals Inc.
-
FDA approval · 2011-01-14FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
The FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) submitted by Verity Pharmaceuticals Inc. This action updates …
-
CLINICAL_TRIALS trial_result · 2010-12-21Clinical Trial Update: Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating prophylactic Memokath urethral stents after prostate brachytherapy in men with prostate cancer; the stud…
-
CLINICAL_TRIALS trial_result · 2010-12-21Clinical Trial Update: Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation [Phase 1]
A Phase 1 study assessing safety and early efficacy signals for combining radiotherapy with zoledronic acid to palliate bone metastases; con…
-
CLINICAL_TRIALS trial_result · 2010-12-14Clinical Trial Update: An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer [Phase 2, Phase 3]
An extension study assessed the long-term safety and tolerability of one-month degarelix depots in prostate cancer, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer [Phase 2]
A Phase 2 study comparing three dosing regimens of a three-month degarelix depot in patients with prostate cancer has completed, with result…